Free Trial
TSE:ACB

Aurora Cannabis 11/6/2024 Earnings Report

Aurora Cannabis logo
C$6.49 -0.20 (-2.99%)
As of 05/5/2025 04:00 PM Eastern

Aurora Cannabis EPS Results

Actual EPS
C$0.05
Consensus EPS
-C$0.30
Beat/Miss
Beat by +C$0.35
One Year Ago EPS
-C$0.70

Aurora Cannabis Revenue Results

Actual Revenue
N/A
Expected Revenue
N/A
Beat/Miss
N/A
YoY Revenue Growth
N/A

Aurora Cannabis Announcement Details

Quarter
Time
Before Market Opens
Conference Call Date
N/A
Conference Call Time
N/A

Conference Call Resources

Conference Call Audio

Earnings Conference Call
Aurora Cannabis
00:00 / 00:00

Aurora Cannabis Earnings Headlines

Elon just did WHAT!?
As you may recall, Biden and the Fed were working on a central bank digital currency, or CBDC. Had they gotten away with it, the Fed and U.S. banks could have seized control of our financial lives forever. But Trump stopped them cold on January 23rd, 2025, when he outlawed CBDCs… Paving the way for Elon Musk's secret master plan.
Is Aurora Cannabis stock a good buy right now?
See More Aurora Cannabis Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Aurora Cannabis? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Aurora Cannabis and other key companies, straight to your email.

About Aurora Cannabis

Aurora Cannabis (TSE:ACB), headquartered in Edmonton, Canada, cultivates and sells medicinal and recreational cannabis through a portfolio of brands that includes Aurora, CanniMed, Daily Special, MedReleaf, and San Rafael '71. Although the company primarily operates in Canada, it has expanded internationally through medical cannabis exporting agreements or cultivation facilities in more than 20 countries.

View Aurora Cannabis Profile

More Earnings Resources from MarketBeat